Synthesis of new fluorescent 2-(2′,2″-bithienyl)-1,3-benzothiazoles
作者:Rosa M.F. Batista、Susana P.G. Costa、M.Manuela M. Raposo
DOI:10.1016/j.tetlet.2004.02.048
日期:2004.3
Bithienyl-1,3-benzothiazole derivatives were synthesised by reacting various 5-formyl-5′-alkoxy- or 5-formyl-5′-N,N-dialkylamino-2,2′-bithiophenes with ortho-aminobenzenethiol in good to excellent yields. Evaluation of the fluorescence properties of these compounds was carried out. They show strong fluorescence in the 450–600 nm region, as well as high quantum yields and large Stokes’ shifts.
cross-coupling reaction between (hetero)aryl boronic esters and arylsulfides was explored, of which universality was exemplified with thirty small molecules and twelve alternating conjugated polymers. Mechanism studies revealed the importance of room temperature and anhydrous condition in reducing the homocoupling defects and enhancing the optoelectronic properties of the conjugated polymers.
Synthesis and evaluation of novel benzothiazole derivatives based on the bithiophene structure as potential radiotracers for β-amyloid plaques in Alzheimer’s disease
作者:Meng-Chao Cui、Zi-Jing Li、Rui-Kun Tang、Bo-Li Liu
DOI:10.1016/j.bmc.2010.02.002
日期:2010.4
In this study, six novel benzothiazole derivatives based on the bithiophene structure were developed as potential beta-amyloid probes. In vitro binding studies using A beta aggregates showed that all of them demonstrated high binding affinities with K-i values ranged from 0.11 to 4.64 nM. In vitro fluorescent staining results showed that these compounds can intensely stained A beta plaques within brain sections of APP/PS1 transgenic mice, animal model for AD. Two radioiodinated compounds [I-125]-2-(5'-iodo-2,2'-bithiophen-5-yl)-6-methoxybenzo[d]thiazole [I-125]10 and [I-125]-2-(2,2'-bithiophen-5-yl)-6-iodobenzo[d]thiazole [I-125]13 were successfully prepared through an iododestannylation reaction. Furthermore, in vitro autoradiography of the AD model mice brain sections showed that both [I-125]10 and [I-125]13 labeled the A beta plaques specifically with low background. In vivo biodistribution studies in normal mice indicated that [I-125]13 exhibited high brain uptake (3.42% ID/g at 2 min) and rapid clearance from the brain (0.53% ID/g at 60 min), while [I-125]10 showed lower brain uptake (0.87% ID/g at 2 min). In conclusion, these preliminary results of this study suggest that the novel radioiodinated benzothiazole derivative [I-125]13 may be a candidate as an in vivo imaging agent for detecting beta-amyloid plaques in the brain of AD patients. (C) 2010 Elsevier Ltd. All rights reserved.